Dongguan, China

Yuzhen Xu


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuzhen Xu: Innovator in Pharmaceutical Science

Introduction

Yuzhen Xu is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. His work focuses on enhancing the bioavailability and effectiveness of medications, which is crucial for patient compliance and treatment success.

Latest Patents

Yuzhen Xu holds a patent for a "Lurasidone solid dispersion and preparation method thereof." This invention relates to a solid dispersion of lurasidone, a medication used to treat certain mental health conditions. The preparation method involves melting a mixture that includes lurasidone, a medicinal hot melt carrier, and optional additives. The resulting solid dispersion exhibits a high dissolution rate, reaching between 30% to 70% in a partial neutral medium, such as pH 6.0. This innovation significantly improves the bioavailability of lurasidone and reduces the food effect, thereby enhancing the medication's efficacy and patient compliance.

Career Highlights

Yuzhen Xu is associated with Sunshine Lake Pharma Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in overcoming the limitations of previous medication formulations, ensuring that patients receive effective treatment without the complications of improper medication.

Collaborations

Yuzhen Xu collaborates with talented professionals in his field, including Ning Tian and Xin Huang. These partnerships foster a creative environment that encourages innovation and the development of new pharmaceutical solutions.

Conclusion

Yuzhen Xu's contributions to pharmaceutical science exemplify the importance of innovation in improving patient care. His patented work on lurasidone solid dispersion showcases his commitment to enhancing medication effectiveness and patient compliance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…